No Data
No Data
Risks Still Elevated At These Prices As Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares Dive 26%
The Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) share price has fared very poorly over the last month, falling by a substantial 26%. Instead of being rewarded, shareholders who h
Trending Industry Today: BJ HEALTH Leads Gains In Retirement Concept Stocks
May 10th - The industry of $Retirement Concept(BK1335.HK)$ is trending higher today with 5 constituents up, 1 constituents down and BJ HEALTH leading Gains.$BJ HEALTH(02389.HK)$ gets a 19.4% boost to
Zhitong Hong Kong Stock Investment Calendar | May 7
Hong Kong Stock Investment Calendar | May 7, 2024
泰達生物:二零二三年年報
TEDA BIOMEDICAL: ANNOUNCEMENT ON ANNUAL RESULTS FOR 2023
Teda Biotech (08189.HK) plans to sell 82.76% of Shanghai Weidi's shares for 10.593 million yuan
Gelonghui, March 27, 丨 Teda Biotech (08189.HK) announced that on January 31, 2024, the company signed an equity transfer agreement. Based on this, the company agreed to sell 82.76% of Shanghai Weidi's shares to the buyer at a cost of RMB 10.593 million. After completion, the company will still hold 17.24% of Shanghai Weidi's shares. In view of Shanghai Weidi's performance over the past two years and uncertainty about future prospects, the board of directors believes that the sale is a good opportunity for the company to monetize its investment in Shanghai. Additionally, considering the proceeds from the sale, the company is able to reallocate its resources to its existing
No Data